Stay updated on PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, reflecting a newer metadata version of the study page.
    Difference
    0.0%
    Check dated 2026-06-05T13:17:10.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.3 to v3.5.4, indicating a metadata change on the page rather than a modification of the study details. The core content of the page remains unchanged.
    Difference
    0.0%
    Check dated 2026-05-14T23:22:58.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a new revision tag: Revision: v3.5.3, indicating a minor update to the record.
    Difference
    0.0%
    Check dated 2026-04-30T16:53:18.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T11:00:09.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-18T17:54:21.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3. Removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:55:33.000Z thumbnail image

Stay in the know with updates to PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.